ORGANOGENESIS HOLDINGS INC. Fair Value Adjustment of Warrants
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Fair Value Adjustment of Warrants of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-09.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2021-03-16
- ORGANOGENESIS HOLDINGS INC. fair value adjustment of warrants for the quarter ending 2018-12-31 was $170.00K.
- ORGANOGENESIS HOLDINGS INC. fair value adjustment of warrants for the quarter ending 2018-09-30 was $50.00K.
- ORGANOGENESIS HOLDINGS INC. fair value adjustment of warrants for the quarter ending 2018-06-30 was $176.00K.
- ORGANOGENESIS HOLDINGS INC. fair value adjustment of warrants for the quarter ending 2018-03-31 was $73.00K.
- ORGANOGENESIS HOLDINGS INC. fair value adjustment of warrants for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- ORGANOGENESIS HOLDINGS INC. fair value adjustment of warrants for fiscal 2018 was $469.00K, a 54.77% decline from fiscal 2017.
- ORGANOGENESIS HOLDINGS INC. fair value adjustment of warrants for fiscal 2017 was $1.04M, a 40.71% increase from fiscal 2016.
- ORGANOGENESIS HOLDINGS INC. fair value adjustment of warrants for fiscal 2016 was $737.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-09 | |||
| 2018-12-31 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $220.00K derived: sum of 2 quarters · filed 2021-03-16 | $396.00K derived: sum of 3 quarters · filed 2021-03-16 | $469.00K 10-K · filed 2021-03-16 |
| 2018-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $226.00K derived: sum of 2 quarters · filed 2019-11-12 | $299.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $249.00K 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $73.00K 10-Q · filed 2019-05-10 | |||
| 2017-12-31 | $1.04M 10-K · filed 2020-03-09 | |||
| 2016-12-31 | $737.00K 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |